Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas

Published:2018-08-30 Issue:1 Volume:32 Page:110-121
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Liu Sandy,Gӧnen Mithat,Stadler Zsofia K.,Weiser Martin R.,Hechtman Jaclyn F.,Vakiani Efsevia,Wang Tao,Vyas Monika,Joneja Upasana,Al-Bayati Moataz,Segal Neil H.,Smith J. Joshua,King Sarah,Guercio Shanna,Ntiamoah Peter,Markowitz Arnold J.,Zhang Liying,Cercek Andrea,Garcia-Aguilar Julio,Saltz Leonard B.,Diaz Luis A.,Klimstra David S.,Shia Jinru^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

This study was also supported by the Rome Milio Lynch Syndrome Foundation.

U.S. Department of Health & Human Services | ACF | Office of Community Services

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-018-0114-7.pdf

Reference23 articles.

1. Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 2017;357:409–13.

2. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med 2015;372:2509–20.

3. Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 2017;18:1182–91.

4. Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, Cattaneo M, et al. Immunotherapy for colorectal cancer: where are we heading? Expert Opin Biol Ther 2017;17:709–21.

5. Le DT, Hubbard-Lucey VM, Morse MA, Heery CR, Dwyer A, Marsilje TH, et al. A Blueprint to Advance Colorectal Cancer Immunotherapies. Cancer Immunol Res 2017;5:942–9.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial;Cancer Cell;2024-09

2. Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer;2024-08-30

3. Comparison of mismatch repair and immune checkpoint protein profile with histopathological parameters in pancreatic, periampullary/ampullary, and choledochal adenocarcinomas;World Journal of Gastrointestinal Oncology;2024-03-15

4. Immune cell infiltrates in peritoneal metastases from colorectal cancer;Frontiers in Immunology;2024-02-07

5. PD-L1 in a South African cohort of endometrial carcinomas: directions for the future;European Journal of Gynaecological Oncology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3